I have confidence also, based mainly on the fact that Tony Barton, the chairman and biggest shareholder, has demonstrated the ability to build a business (he was founder of a bank) and has a great deal of financing knowledge and banking experience. His past business experience would have provided a wealth of contacts, some of whom would undoubtedly prove to be useful as well.
Add to this the fact that KRR has been one of the best run businesses so far with very few CRs and very low admin outgoings, incl v.low dir fees,
- Forums
- ASX - By Stock
- KRR
- Ann: HPA Project - DFS Update
Ann: HPA Project - DFS Update, page-55
-
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.001(6.25%) |
Mkt cap ! $12.98M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $2.176K | 242.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 30510620 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 90905 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 30510620 | 0.008 |
5 | 3869627 | 0.007 |
7 | 7989696 | 0.006 |
12 | 8038888 | 0.005 |
4 | 4349990 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 90905 | 1 |
0.010 | 3506377 | 10 |
0.011 | 1900100 | 6 |
0.012 | 938734 | 8 |
0.013 | 676263 | 3 |
Last trade - 15.46pm 10/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
KRR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online